Department of Pediatrics, University of California, San Diego, La Jolla, California.
Department of Pediatrics, University of California, San Diego, La Jolla, California; Department of Pediatrics, Rady Children's Hospital, San Diego, California.
Cell Mol Gastroenterol Hepatol. 2021;12(4):1353-1371. doi: 10.1016/j.jcmgh.2021.06.015. Epub 2021 Jun 29.
BACKGROUND & AIMS: Congenital tufting enteropathy (CTE) is an intractable diarrheal disease of infancy caused by mutations of epithelial cell adhesion molecule (EpCAM). The cellular and molecular basis of CTE pathology has been elusive. We hypothesized that the loss of EpCAM in CTE results in altered lineage differentiation and defects in absorptive enterocytes thereby contributing to CTE pathogenesis.
Intestine and colon from mice expressing a CTE-associated mutant form of EpCAM (mutant mice) were evaluated for specific markers by quantitative real-time polymerase chain reaction, Western blotting, and immunostaining. Body weight, blood glucose, and intestinal enzyme activity were also investigated. Enteroids derived from mutant mice were used to assess whether the decreased census of major secretory cells could be rescued.
Mutant mice exhibited alterations in brush-border ultrastructure, function, disaccharidase activity, and glucose absorption, potentially contributing to nutrient malabsorption and impaired weight gain. Altered cell differentiation in mutant mice led to decreased enteroendocrine cells and increased numbers of nonsecretory cells, though the hypertrophied absorptive enterocytes lacked key features, causing brush border malfunction. Further, treatment with the Notch signaling inhibitor, DAPT, increased the numbers of major secretory cell types in mutant enteroids (graphical abstract 1).
Alterations in intestinal epithelial cell differentiation in mutant mice favor an increase in absorptive cells at the expense of major secretory cells. Although the proportion of absorptive enterocytes is increased, they lack key functional properties. We conclude that these effects underlie pathogenic features of CTE such as malabsorption and diarrhea, and ultimately the failure to thrive seen in patients.
先天性簇状肠病(CTE)是一种由上皮细胞黏附分子(EpCAM)突变引起的婴幼儿难治性腹泻病。CTE 病理学的细胞和分子基础一直难以捉摸。我们假设 CTE 中 EpCAM 的缺失导致谱系分化改变和吸收性肠细胞缺陷,从而导致 CTE 发病机制。
通过定量实时聚合酶链反应、Western 印迹和免疫染色评估表达 CTE 相关突变形式 EpCAM 的小鼠的肠和结肠的特定标志物。还研究了体重、血糖和肠酶活性。从突变小鼠中分离的类器官用于评估主要分泌细胞数量减少是否可以得到挽救。
突变小鼠表现出刷状边界超微结构、功能、双糖酶活性和葡萄糖吸收改变,可能导致营养吸收不良和体重增加受损。突变小鼠的细胞分化改变导致肠内分泌细胞减少和非分泌细胞数量增加,尽管肥大的吸收性肠细胞缺乏关键特征,导致刷状边界功能障碍。此外,用 Notch 信号通路抑制剂 DAPT 处理可增加突变类器官中的主要分泌细胞类型数量(图摘要 1)。
突变小鼠的肠上皮细胞分化改变有利于吸收细胞的增加,而牺牲主要分泌细胞。尽管吸收性肠细胞的比例增加,但它们缺乏关键的功能特性。我们得出结论,这些影响是 CTE 发病特征的基础,如吸收不良和腹泻,最终导致患者生长不良。